(HPQ) HP - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US40434L1052
Stock:
Total Rating 34
Risk 47
Buy Signal -0.52
| Risk 5d forecast | |
|---|---|
| Volatility | 31.2% |
| Relative Tail Risk | -3.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.22 |
| Alpha | -61.39 |
| Character TTM | |
|---|---|
| Beta | 1.259 |
| Beta Downside | 1.794 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.23% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Description: HPQ HP
HP Inc. provides personal computing, printing, 3D printing, hybrid work, gaming, and other related technologies in the United States and internationally. The company operates through three segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment offers commercial and consumer desktops and notebooks, workstations, thin clients, retail point-of-sale systems, displays, software, hybrid systems, and endpoint security and services, as well as lifecycle services, including support and deployment, configurations, and extended warranty services. The Printing segment provides consumer and commercial printer hardware, supplies, and solutions, as well as office and home printing solutions; and focuses on graphics, 3D printing, and personalization solutions for the commercial and industrial markets. The Corporate Investments segment is involved in the business incubation and investment projects. It serves small- and medium-sized businesses, public sector, and enterprises. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.51b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.46 > 1.0 |
| NWC/Revenue: -12.56% < 20% (prev -14.11%; Δ 1.54% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.71b > Net Income 2.51b |
| Net Debt (6.54b) to EBITDA (4.07b): 1.61 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (932.0m) vs 12m ago -2.61% < -2% |
| Gross Margin: 20.25% > 18% (prev 0.22%; Δ 2003 % > 0.5%) |
| Asset Turnover: 139.8% > 50% (prev 138.4%; Δ 1.36% > 0%) |
| Interest Coverage Ratio: 6.25 > 6 (EBITDA TTM 4.07b / Interest Expense TTM 502.0m) |
Altman Z'' -0.82
| A: -0.17 (Total Current Assets 22.23b - Total Current Liabilities 29.29b) / Total Assets 41.53b |
| B: -0.05 (Retained Earnings -2.03b / Total Assets 41.53b) |
| C: 0.08 (EBIT TTM 3.14b / Avg Total Assets 40.23b) |
| D: -0.06 (Book Value of Equity -2.48b / Total Liabilities 38.13b) |
| Altman-Z'' Score: -0.82 = CCC |
Beneish M -3.16
| DSRI: 0.74 (Receivables 5.33b/6.90b, Revenue 56.23b/53.88b) |
| GMI: 1.08 (GM 20.25% / 21.85%) |
| AQI: 1.01 (AQ_t 0.39 / AQ_t-1 0.39) |
| SGI: 1.04 (Revenue 56.23b / 53.88b) |
| TATA: -0.03 (NI 2.51b - CFO 3.71b) / TA 41.53b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of HPQ shares?
As of March 02, 2026, the stock is trading at USD 18.99 with a total of 23,564,729 shares traded.
Over the past week, the price has changed by +2.15%, over one month by -1.96%, over three months by -21.31% and over the past year by -40.14%.
Over the past week, the price has changed by +2.15%, over one month by -1.96%, over three months by -21.31% and over the past year by -40.14%.
Is HPQ a buy, sell or hold?
HP has received a consensus analysts rating of 3.24.
Therefor, it is recommend to hold HPQ.
- StrongBuy: 2
- Buy: 2
- Hold: 12
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the HPQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.1 | 5.6% |
| Analysts Target Price | 20.1 | 5.6% |
HPQ Fundamental Data Overview February 27, 2026
P/E Trailing = 6.8717
P/E Forward = 5.8962
P/S = 0.3027
P/EG = 1.2549
Revenue TTM = 56.23b USD
EBIT TTM = 3.14b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 8.82b USD (from longTermDebt, last fiscal year)
Short Term Debt = 861.0m USD (from shortTermDebt, last quarter)
Debt = 9.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.54b USD (from netDebt column, last quarter)
Enterprise Value = 23.57b USD (17.02b + Debt 9.70b - CCE 3.15b)
Interest Coverage Ratio = 6.25 (Ebit TTM 3.14b / Interest Expense TTM 502.0m)
EV/FCF = 8.19x (Enterprise Value 23.57b / FCF TTM 2.88b)
FCF Yield = 12.21% (FCF TTM 2.88b / Enterprise Value 23.57b)
FCF Margin = 5.12% (FCF TTM 2.88b / Revenue TTM 56.23b)
Net Margin = 4.46% (Net Income TTM 2.51b / Revenue TTM 56.23b)
Gross Margin = 20.25% ((Revenue TTM 56.23b - Cost of Revenue TTM 44.84b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 20.23%)
Tobins Q-Ratio = 0.57 (Enterprise Value 23.57b / Total Assets 41.53b)
Interest Expense / Debt = 0.91% (Interest Expense 88.0m / Debt 9.70b)
Taxrate = 18.78% (126.0m / 671.0m)
NOPAT = 2.55b (EBIT 3.14b * (1 - 18.78%))
Current Ratio = 0.76 (Total Current Assets 22.23b / Total Current Liabilities 29.29b)
Debt / Equity = 2.85 (Debt 9.70b / totalStockholderEquity, last quarter 3.41b)
Debt / EBITDA = 1.61 (Net Debt 6.54b / EBITDA 4.07b)
Debt / FCF = 2.27 (Net Debt 6.54b / FCF TTM 2.88b)
Total Stockholder Equity = 221.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.24% (Net Income 2.51b / Total Assets 41.53b)
RoE = 1135 % (out of range, set to none) (Net Income TTM 2.51b / Total Stockholder Equity 221.0m)
RoCE = 34.69% (EBIT 3.14b / Capital Employed (Equity 221.0m + L.T.Debt 8.82b))
RoIC = 27.81% (NOPAT 2.55b / Invested Capital 9.16b)
WACC = 6.99% (E(17.02b)/V(26.72b) * Re(10.56%) + D(9.70b)/V(26.72b) * Rd(0.91%) * (1-Tc(0.19)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.92%
[DCF] Terminal Value 80.61% ; FCFF base≈3.03b ; Y1≈2.75b ; Y5≈2.39b
[DCF] Fair Price = 50.86 (EV 53.24b - Net Debt 6.54b = Equity 46.69b / Shares 918.0m; r=6.99% [WACC]; 5y FCF grow -11.59% → 2.90% )
EPS Correlation: -47.46 | EPS CAGR: -7.38% | SUE: 1.19 | # QB: 1
Revenue Correlation: -27.19 | Revenue CAGR: -3.48% | SUE: 2.68 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.71 | Chg7d=-0.028 | Chg30d=-0.032 | Revisions Net=-3 | Analysts=12
EPS current Year (2026-10-31): EPS=2.92 | Chg7d=-0.137 | Chg30d=-0.187 | Revisions Net=-6 | Growth EPS=-6.5% | Growth Revenue=+2.2%
EPS next Year (2027-10-31): EPS=3.02 | Chg7d=-0.126 | Chg30d=-0.194 | Revisions Net=-6 | Growth EPS=+3.4% | Growth Revenue=+0.4%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.0% (Discount Rate 10.6% - Earnings Yield 14.6%)
[Growth] Growth Spread = +10.5% (Analyst 6.5% - Implied -4.0%)
P/E Forward = 5.8962
P/S = 0.3027
P/EG = 1.2549
Revenue TTM = 56.23b USD
EBIT TTM = 3.14b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 8.82b USD (from longTermDebt, last fiscal year)
Short Term Debt = 861.0m USD (from shortTermDebt, last quarter)
Debt = 9.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.54b USD (from netDebt column, last quarter)
Enterprise Value = 23.57b USD (17.02b + Debt 9.70b - CCE 3.15b)
Interest Coverage Ratio = 6.25 (Ebit TTM 3.14b / Interest Expense TTM 502.0m)
EV/FCF = 8.19x (Enterprise Value 23.57b / FCF TTM 2.88b)
FCF Yield = 12.21% (FCF TTM 2.88b / Enterprise Value 23.57b)
FCF Margin = 5.12% (FCF TTM 2.88b / Revenue TTM 56.23b)
Net Margin = 4.46% (Net Income TTM 2.51b / Revenue TTM 56.23b)
Gross Margin = 20.25% ((Revenue TTM 56.23b - Cost of Revenue TTM 44.84b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 20.23%)
Tobins Q-Ratio = 0.57 (Enterprise Value 23.57b / Total Assets 41.53b)
Interest Expense / Debt = 0.91% (Interest Expense 88.0m / Debt 9.70b)
Taxrate = 18.78% (126.0m / 671.0m)
NOPAT = 2.55b (EBIT 3.14b * (1 - 18.78%))
Current Ratio = 0.76 (Total Current Assets 22.23b / Total Current Liabilities 29.29b)
Debt / Equity = 2.85 (Debt 9.70b / totalStockholderEquity, last quarter 3.41b)
Debt / EBITDA = 1.61 (Net Debt 6.54b / EBITDA 4.07b)
Debt / FCF = 2.27 (Net Debt 6.54b / FCF TTM 2.88b)
Total Stockholder Equity = 221.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.24% (Net Income 2.51b / Total Assets 41.53b)
RoE = 1135 % (out of range, set to none) (Net Income TTM 2.51b / Total Stockholder Equity 221.0m)
RoCE = 34.69% (EBIT 3.14b / Capital Employed (Equity 221.0m + L.T.Debt 8.82b))
RoIC = 27.81% (NOPAT 2.55b / Invested Capital 9.16b)
WACC = 6.99% (E(17.02b)/V(26.72b) * Re(10.56%) + D(9.70b)/V(26.72b) * Rd(0.91%) * (1-Tc(0.19)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.92%
[DCF] Terminal Value 80.61% ; FCFF base≈3.03b ; Y1≈2.75b ; Y5≈2.39b
[DCF] Fair Price = 50.86 (EV 53.24b - Net Debt 6.54b = Equity 46.69b / Shares 918.0m; r=6.99% [WACC]; 5y FCF grow -11.59% → 2.90% )
EPS Correlation: -47.46 | EPS CAGR: -7.38% | SUE: 1.19 | # QB: 1
Revenue Correlation: -27.19 | Revenue CAGR: -3.48% | SUE: 2.68 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.71 | Chg7d=-0.028 | Chg30d=-0.032 | Revisions Net=-3 | Analysts=12
EPS current Year (2026-10-31): EPS=2.92 | Chg7d=-0.137 | Chg30d=-0.187 | Revisions Net=-6 | Growth EPS=-6.5% | Growth Revenue=+2.2%
EPS next Year (2027-10-31): EPS=3.02 | Chg7d=-0.126 | Chg30d=-0.194 | Revisions Net=-6 | Growth EPS=+3.4% | Growth Revenue=+0.4%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.0% (Discount Rate 10.6% - Earnings Yield 14.6%)
[Growth] Growth Spread = +10.5% (Analyst 6.5% - Implied -4.0%)